These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28823893)

  • 21. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.
    Miyake Y; Keusch JJ; Wang L; Saito M; Hess D; Wang X; Melancon BJ; Helquist P; Gut H; Matthias P
    Nat Chem Biol; 2016 Sep; 12(9):748-54. PubMed ID: 27454931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
    Wang XX; Wan RZ; Liu ZP
    Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
    Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
    Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of mutant hERG stability by inhibition of HDAC6.
    Li P; Kurata Y; Endang M; Ninomiya H; Higaki K; Taufiq F; Morikawa K; Shirayoshi Y; Horie M; Hisatome I
    J Mol Cell Cardiol; 2018 Feb; 115():158-169. PubMed ID: 29355491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
    Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
    J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylation/deacetylation and microtubule associated proteins influence flagellar axonemal stability and sperm motility.
    Chawan V; Yevate S; Gajbhiye R; Kulkarni V; Parte P
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33200789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
    Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
    Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
    Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase.
    Chen J; Zhang J; Shaik NF; Yi B; Wei X; Yang XF; Naik UP; Summer R; Yan G; Xu X; Sun J
    J Biol Chem; 2019 Dec; 294(51):19565-19576. PubMed ID: 31719145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
    Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M
    Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity.
    Wu JY; Xiang S; Zhang M; Fang B; Huang H; Kwon OK; Zhao Y; Yang Z; Bai W; Bepler G; Zhang XM
    J Biol Chem; 2018 Feb; 293(6):1976-1993. PubMed ID: 29259132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth.
    Van Helleputte L; Kater M; Cook DP; Eykens C; Rossaert E; Haeck W; Jaspers T; Geens N; Vanden Berghe P; Gysemans C; Mathieu C; Robberecht W; Van Damme P; Cavaletti G; Jarpe M; Van Den Bosch L
    Neurobiol Dis; 2018 Mar; 111():59-69. PubMed ID: 29197621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity.
    Francelle L; Outeiro TF; Rappold GA
    Sci Rep; 2020 Apr; 10(1):6064. PubMed ID: 32269243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDAC6 inhibition induces the failure of mouse early embryonic development.
    Wang H; Ling L; Ai L; Bai L
    J Cell Physiol; 2019 Jun; 234(6):8752-8759. PubMed ID: 30370558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
    Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
    Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Evaluation of an
    Tago T; Toyohara J; Ishii K
    ACS Chem Neurosci; 2021 Feb; 12(4):746-755. PubMed ID: 33502174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC6 inhibition disrupts maturational progression and meiotic apparatus assembly in mouse oocytes.
    Ling L; Hu F; Ying X; Ge J; Wang Q
    Cell Cycle; 2018; 17(5):550-556. PubMed ID: 28598228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
    Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
    Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.